Allosteric inhibition of HER2 by Moesin-mimicking compounds targets HER2-positive cancers and brain metastases. Faure C, Djerbi-Bouillie R, Domingot A, Bouzinba-Segard H, et al. Cancer Res 2021 Sep 7. pii: 0008-5472.CAN-21-0162.

Read + Share

Amedeo Smart

Independent Medical Education

Faure C, Djerbi-Bouillie R, Domingot A, Bouzinba-Segard H, et al. Allosteric inhibition of HER2 by Moesin-mimicking compounds targets HER2-positive cancers and brain metastases. Cancer Res 2021 Sep 7. pii: 0008-5472.CAN-21-0162.
PMID: 34493594